XGene Pharmaceutical

PharmaceuticalsSeries DShanghai, Chinaxgenepharm.com

Latest round

Series D

Last raised

Jul 2026

Total raised

$97M

Investors

15

About XGene Pharmaceutical

, trading as XGene Pharmaceutical, is medicine research that focuses on providing molecular medicine for pain, communicable disease and tumor. The company main business is the development and combination therapy of small molecule drugs for the treatment of pain, infectious diseases and tumors. The company has a self-developed product XG005 which is a non-opioid analgesic product. The company's revenue is generated by providing XG005 which is a non-opioid analgesic product, and combination therapy of small molecule drugs for the treatment of pain, infectious diseases and tumors.

Who invested in XGene Pharmaceutical

15 investors across 5 rounds

See all investors in XGene Pharmaceutical

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jul 28, 2026

    Amount

    $37M

    Investors

    Locked

  2. Series C

    Nov 5, 2021

    Amount

    $40M

    Investors

    Locked

  3. Series B

    May 4, 2019

    Amount

    Undisclosed

    Investors

    Locked

  4. Series B

    Oct 24, 2018

    Amount

    $20M

    Investors

    Locked

  5. Series A

    Oct 1, 2017

    Amount

    Undisclosed

    Investors

    Locked

Questions about XGene Pharmaceutical

Who invested in XGene Pharmaceutical?

XGene Pharmaceutical has 15 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has XGene Pharmaceutical raised?

XGene Pharmaceutical has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did XGene Pharmaceutical last raise money?

XGene Pharmaceutical's most recent round on record is a Series D, in Jul 2026.

What does XGene Pharmaceutical do?

, trading as XGene Pharmaceutical, is medicine research that focuses on providing molecular medicine for pain, communicable disease and tumor.

Where is XGene Pharmaceutical headquartered?

XGene Pharmaceutical is headquartered in Shanghai, China.

Which VCs invest in companies like XGene Pharmaceutical?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at XGene Pharmaceutical's stage. Their profiles are linked below.

Raising like XGene Pharmaceutical? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.